enGene Holdings Inc. Share Price
ENGN$0.00
+0.00 (0.00%) enGene Holdings Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
enGene Holdings Inc. Share Price Chart
$0.00
Please wait...
About enGene Holdings Inc.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.
enGene Holdings Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on enGene Holdings Inc. Share Price
Can I buy enGene Holdings Inc. shares in India?
Yes. You can buy enGene Holdings Inc. in India by opening an international trading account.
What is the share price of enGene Holdings Inc.?
As on 07 Feb '26, the share price of enGene Holdings Inc. ENGN is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of enGene Holdings Inc.?
The 5 year returns of enGene Holdings Inc. is as on 07 Feb '26.
What are the high & low stock price of enGene Holdings Inc. today?
enGene Holdings Inc. stock price hit a high of $0.00 and low of $0.00 as on 07 Feb '26.
What is the 52-week high and low of enGene Holdings Inc. stock?
The 52-week high of enGene Holdings Inc. stock is $0.00, while the 52-week low is $0.00 as on 07 Feb '26.